4th Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$480,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017; H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions; S. 1519 National Defense Authorization Act for Fiscal Year 2018- Generic drug pricing transparency and TRICARE Pharmacy Benefits Provisions

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Treasury, Dept of; White House Office; Natl Economic Council (NEC); Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Government Accountability Office (GAO); SENATE; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP)

Bills named: S. 1519 (115th), H.R. 2810 (115th)

Pharmacy PHA

Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act; H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017; HR 749, Lower Drug Costs through Competition Act

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Defense, Dept of (DOD); Treasury, Dept of; Natl Economic Council (NEC); Medicare Payment Advisory Commission (MedPAC); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Government Accountability Office (GAO); White House Office; Health Resources & Services Administration (HRSA)

Bills named: H.R. 421 (115th), H.R. 749 (115th), H.R. 2871 (115th)

Alcohol and Drug Abuse ALC

Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions; H.R. 1854/S. 778, Prescription Drug Monitoring Act of 2017; S 892, Opioid Addiction Prevention Act of 2017; HR 3528, Every Prescription Conveyed Securely Act; H.R. 3545, Overdose Prevention and Patient Safety Act; S. 1850, Protecting Jessica Grubbs Legacy Act; H.R. 1271, DXM Abuse Prevention Act of 2017; H.R. 1375, Prescriber Support Act of 2017; S. 523, Budgeting for Opioid Addiction Treatment Act; S. 581, Jessies Law; S 1079, Protecting Americans from Dangerous Opioids Act; H.R. 4236, MONITOR Act of 2017; H.R. 3991, Expanded Access to Opioid Abuse Treatment Act of 2017; H.R. 4275, Empowering Pharmacists in the Fight Against Opioid Abuse Act

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); Medicare Payment Advisory Commission (MedPAC); White House Office; Office of Personnel Management (OPM); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Treasury, Dept of; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Bills named: S. 523 (115th), H.R. 3528 (115th), S. 1850 (115th), H.R. 1375 (115th), H.R. 1854 (115th), H.R. 4275 (115th), H.R. 3991 (115th), H.R. 3545 (115th), S. 581 (115th), S. 778 (115th), H.R. 4236 (115th), H.R. 1271 (115th)

Taxation/Internal Revenue Code TAX

Unified Framework for Fixing Our Broken Tax Code; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017; H.R. 1, Tax Cuts and Jobs Act of 2017

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Treasury, Dept of; Government Accountability Office (GAO); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Drug Enforcement Administration (DEA); SENATE; Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Substance Abuse & Mental Health Services Administration (SAMHSA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); White House Office; Defense, Dept of (DOD)

Bills named: S. 205 (115th), H.R. 631 (115th), H.R. 1 (115th)

Health Issues HCR

S. 222, The Obama Care Replacement Act; S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017; Drug Pricing Transparency

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); White House Office; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Office of Personnel Management (OPM); Natl Economic Council (NEC); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Government Accountability Office (GAO); Drug Enforcement Administration (DEA); SENATE; Defense, Dept of (DOD)

Bills named: S. 222 (115th), H.R. 1776 (115th), S. 41 (115th), H.R. 1245 (115th), S. 771 (115th), H.R. 242 (115th), S. 469 (115th)

Medicare/Medicaid MMM

H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes; S.637 Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017; HR 394/ S 85, Restoring Access to Medication Act; HR 3921/S 1827, KIDS Act of 2017; HR 3271, Protecting Access to Diabetes Supplies Act of 2017; S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017 Discussion draft, preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies; Centers for Medicare and Medicaid Services (CMS) Proposed Rule for the 2019 Medicare Part D Plan Year, pharmacy provisions; Electronic prior authorization (ePA) discussion draft

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); Agriculture, Dept of (USDA); Substance Abuse & Mental Health Services Administration (SAMHSA); Drug Enforcement Administration (DEA); Office of Natl Drug Control Policy (NDCP); SENATE; Natl Economic Council (NEC); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); Government Accountability Office (GAO); Treasury, Dept of; White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1939 (115th), S. 870 (115th), S. 109 (115th), H.R. 394 (115th), H.R. 3271 (115th), S. 413 (115th), S. 637 (115th), H.R. 1316 (115th), H.R. 3921 (115th), H.R. 1038 (115th), H.R. 592 (115th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; H.amdt. 278, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; H.R. 2430 the FDA Reauthorization Act (FDARA) of 2017; S.934 FDA Reauthorization Act of 2017;

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: SENATE; Agriculture, Dept of (USDA); Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); Defense, Dept of (DOD); White House Office; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Office of Natl Drug Control Policy (NDCP); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 934 (115th), H.R. 2430 (115th), H.R. 1628 (115th)

Animals ANI

Issues related to compounded pharmaceuticals for animals; H.R. 623, FairnesstoPetOwnersActof 2017

LobbyistCovered position, as disclosed
PHILLIP ADAM HARBISON New Legislative Director, Rep H. Morgan Griffith
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
KEVIN SCHWEERS —

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); SENATE; Office of Personnel Management (OPM); Government Accountability Office (GAO); Office of Natl Drug Control Policy (NDCP); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Natl Economic Council (NEC); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Treasury, Dept of; Substance Abuse & Mental Health Services Administration (SAMHSA); White House Office

Bills named: H.R. 623 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.